Consultations in a virtual world
Consultations in a virtual world
The art of active listening
A trade-off you no longer have to make in this changing world
Truly achieving a patient-focused cultural shift means pharma leaders must build momentum behind the necessity of partnering with patients to capture and incorporate their valuable insights, say Dawn Lobban and Peter Impey
O4 Research’s Moneeb Saddiq and Andrea Parke consider whether the patient-centricity story is complete or still evolving
Eliran Malki, co-founder and CEO of Belong.Life, explores what pharma can do to engage the modern patient
ICON’s Gretchen Goller on getting the patient perspective on clinical trial participation
Keeping the needs of patients as a guiding principle has been key to Kyowa Kirin’s recent success, says Richard Johnson
On January 30, 2020, the WHO declared the novel acute respiratory infection caused by the “SARS-CoV-2” virus, termed “Coronavirus Disease-2019 (COVID-19)” as a Public Health Emergency of International Concern.{9} As of July 20, 2020, over 14 million people worldwide are confirmed to be infected, leading to increasing fatality rates.{10}
Creating space for open dialogue between patients and healthcare professionals
Getting medicines to those who need them
Europe has endured some difficult months, but there is growing confidence in the eurozone’s ability to push back against the pandemic
Understanding the complexities of behaviour change
What’s in a name? How changing emphasis can be a game changer
The modern digital lab will truly transform how biopharmaceutical products are created and brought to market